The Dolo Debate – Is Pharma Paying for Prescriptions?

Dolo650 became a household medicine during the pandemic. … but the latest controversy of freebies being given to promote it has yet again brought the spotlight on the questionable marketing practices of pharma companies. Host Kiran Somvanshi probed the issue with stakeholders – Dr. Viranchi Shah, National President, Indian Drug Manufacturers Association (IDMA), Malini Aisola, National Co-convenor of All India Drug Action Network (AIDAN), Santanu Chatterjee, General Secretary of Federation of Medical and Sales Representatives’ Association of India (FMRAI) and Vikas Dandekar, Editor – Pharma & Healthcare at ET Prime. Credits: CNBC TV18, WION and Medical Dialogues Youtube Channel.